Skip to content

Author

Menghui Yuan

We have 2 of 9 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

NPAS2 promotes MASLD and hepatocarcinogenesis through SIRT1-mediated PPARγ suppression

Emerging evidence links circadian disruption to metabolic dysfunction-associated steatotic liver disease (MASLD), but the underlying mechanisms remain elusive. NPAS2, a core circadian regulator, has an undefined role in the pathogenesis of MASLD and its progression to hepatocellular carcinoma (HCC). This study aime...

Jiao Mu, Jia-Li Ye, Jia-Hao Zhang et al. · 0 citations
Jul 2026

Prognostic Value of Number of Metastatic Nodes in School-Age Children and Adolescents With Papillary Thyroid Cancer: A Real-Life Multicenter Study.

The number of metastatic nodes is a predominant factor associated with persistent disease, and incorporating quantitative assessment of metastatic nodes may improve risk stratification in SACAs with N1b PTC.

Liu Xiao, Wei Chang, Hui-Juan Feng et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.